Skip to main content
. Author manuscript; available in PMC: 2020 Nov 1.
Published in final edited form as: Endocr Relat Cancer. 2019 Nov;26(11):R627–R652. doi: 10.1530/ERC-19-0165

Figure 5. Proportion of PPGL patients with partial response or stable disease after PRRT.

Figure 5.

Plots of individual studies and pooled proportion (with 95% confidence interval) of inoperable/metastatic PPGL patients with response or stable disease after PRRT (random-effects model). The size of the squares indicates the weight of each study. Mild heterogeneity among studies was evident (I-square test = 37.6%, p=0.099).